Jaffrey, Samie

Samie Jaffrey, PhD, Greenberg-Starr Professor of Pharmacology at Cornell University, studies protein expression and RNA regulatory pathways, specifically how they function in neurodevelopmental disorders.

Which is the right FMRP for Therapeutic Development of Fragile X Syndrome?

FRAXA Research Foundation 2016 Grants • Completed Research Grants • Cornell University • Disease Mechanisms • Gan, Wen-Biao • Jaffrey, Samie • Treatment Targets
Which is the right FMRP for Therapeutic Development of Fragile X Syndrome?

With a 2-year, $90,000 grant from FRAXA Research Foundation over 2016-17, Dr. Samie Jaffrey at Weill Medical College of Cornell University explored which FMRP isoform is the best target to treat Fragile X syndrome.

Samie Jaffrey, PhD, at Weill Medical College of Cornell University, FRAXA research grantRead more

Scientists Uncover Trigger for Fragile X Syndrome

FRAXA Research Foundation Cornell University • Jaffrey, Samie • Research Updates , , ,
Scientists Uncover Trigger for Fragile X Syndrome

A new study led by Weill Cornell Medical College scientists shows that Fragile X syndrome occurs because of a mechanism that shuts off the gene associated with the disease. The findings, published today in Science, also show that a compound that blocks this silencing mechanism can prevent Fragile X syndrome – suggesting a similar therapy may be possible for 20 other diseases that range from mental retardation to multisystem failure.

Samie Jaffrey, PhD, at Weill Medical College of Cornell University, FRAXA research grantRead more